Legal Representation
Attorney
Bruce W. Schwab
USPTO Deadlines
Application History
27 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jan 28, 2005 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Jan 28, 2005 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
May 4, 2004 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Apr 29, 2004 | CFIT | O | CASE FILE IN TICRS | Loading... |
Apr 19, 2004 | I | PAPER RECEIVED | Loading... | |
Apr 19, 2004 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Mar 12, 2004 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Oct 23, 2003 | I | PAPER RECEIVED | Loading... | |
Oct 23, 2003 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Jun 2, 2003 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
May 5, 2003 | I | PAPER RECEIVED | Loading... | |
May 5, 2003 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Dec 12, 2002 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
Dec 2, 2002 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Nov 4, 2002 | I | PAPER RECEIVED | Loading... | |
Nov 4, 2002 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
Nov 4, 2002 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
May 13, 2002 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Apr 25, 2002 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Nov 6, 2001 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Aug 14, 2001 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jul 25, 2001 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
Mar 11, 2001 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Oct 23, 2000 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Sep 26, 2000 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Sep 26, 2000 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Sep 26, 2000 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for treatment of diseases and medical conditions of the peripheral nerve, of the adrenergic and cholinergic receptors; of the skeletal and smooth muscle systems, cardiovascular systems, endocrine and hormone systems, blood circulatory and immunological systems, of the synoptic and neuroeffector junctional sites, of the reproductive, skeletal and autacoid systems, the alimentary and excretory systems, and the histamine and central nervous systems, in the nature of drugs for delivery in aerosol form as fine dry particles to the deep lung, otherwise requiring other drug delivery means for treatment
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005